AbbVie, Bristol Myers Squibb and Eli Lilly appear “relatively well-positioned,” while Novartis and Roche look more at risk, ...

Paul McGinley was one of the heavy hitters in the golf and business community invited to help US President Donald Trump open his new Aberdeenshire golf course.

Amgen Inc. (AMGN) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, AMGN's 50-day simple moving average broke out above its 200-day ...

Amgen (AMGN) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives a good ...

With a $5 billion investment, the 3,000-employee campus leads biomanufacturing innovation while embracing AI, education and ...

Cetera Investment Advisers just upped their Amgen game, acquiring an additional 26,309 shares, now holding a hefty 226,219 ...

Five Dogs of the Dow stocks are not only higher on the year but still offer big yields, a degree of safety from tariffs, and ...

In the latest close session, Amgen (AMGN) was down 1.73% at $301.29. The stock's change was less than the S&P 500's daily gain of 0.02%. Meanwhile, the Dow experienced a drop of 0.14%, and the ...